Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE-PA) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Global Medical REIT (GMRE-PA) over the last 9 years, with Q3 2025 value amounting to $294000.0.

  • Global Medical REIT's Consolidated Net Income fell 8387.27% to $294000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 million, marking a year-over-year increase of 15639.05%. This contributed to the annual value of $4.2 million for FY2024, which is 7297.56% down from last year.
  • According to the latest figures from Q3 2025, Global Medical REIT's Consolidated Net Income is $294000.0, which was down 8387.27% from $207000.0 recorded in Q2 2025.
  • Global Medical REIT's Consolidated Net Income's 5-year high stood at $12.8 million during Q2 2023, with a 5-year trough of -$12.0 million in Q1 2024.
  • Moreover, its 5-year median value for Consolidated Net Income was $207000.0 (2025), whereas its average is -$879235.3.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first soared by 29659.39% in 2022, then crashed by 256597.94% in 2024.
  • Over the past 5 years, Global Medical REIT's Consolidated Net Income (Quarter) stood at -$4.9 million in 2021, then skyrocketed by 237.4% to $6.8 million in 2022, then tumbled by 66.1% to $2.3 million in 2023, then surged by 151.86% to $5.8 million in 2024, then crashed by 94.9% to $294000.0 in 2025.
  • Its last three reported values are $294000.0 in Q3 2025, $207000.0 for Q2 2025, and $1.4 million during Q1 2025.